Samsung's Ontruzant Becomes First Trastuzumab Biosimilar Approved In EU

 
• By Jung Won Shin
Samsung Bioepis
Samsung Bioepis researchers conducting a study • Source: Samsung Bioepis

More from New Products

More from Scrip